Newsroom

Dec 08, 2024

Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting

View

Dec 07, 2024

Orca Bio Presents Clinical Results on Use of Orca-Q without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting

View

Nov 05, 2024

Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting

View

Jun 05, 2024

Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T

View

May 23, 2024

Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting

View

Apr 11, 2024

Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT

View

Feb 23, 2024

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

View

Jan 03, 2024

Orca Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

View